Literature DB >> 1378906

Transrectal microwave hyperthermia for benign prostatic hyperplasia: long-term clinical, pathological and ultrastructural patterns.

F Montorsi1, L Galli, G Guazzoni, R Colombo, G Bulfamante, L Barbieri, V Matozzo, V Grazioli, P Rigatti.   

Abstract

Transrectal microwave hyperthermia of the prostate was administered to 191 patients with bladder outlet obstruction due to benign prostatic hyperplasia who were either at poor operative risk or who refused surgery. Patients were divided in 2 groups according to age and they underwent either 5 or 10, 60-minute sessions of hyperthermia, with a calculated intraprostatic temperature of 42.5 plus or minus 0.5C. Light and electron microscopy showed no irreversible damage at the glandular epithelium but did demonstrate a significant increase in neoformed intraprostatic capillary-like vessels. At 1, 12 and 24 months residual urine volume was significantly decreased in the majority of patients but only a minor amelioration of urinary flow rates and subjective symptoms was observed. According to maximum flow nomograms all patients were still obstructed postoperatively. Transrectal hyperthermia cannot be considered a genuine alternative to surgery for patients with bladder outlet obstruction due to benign prostatic hyperplasia.

Entities:  

Mesh:

Year:  1992        PMID: 1378906     DOI: 10.1016/s0022-5347(17)36584-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

Review 1.  Transurethral microwave thermotherapy: past, present and future.

Authors:  J J de la Rosette; A Tubaro; K Höfner; S S Carter
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

2.  Transurethral laser ablation of the prostate--long-term results.

Authors:  A J Costello; D G Lusaya; H R Crowe
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

3.  Urodynamic indices change as a result of transrectal microwave thermotherapy (TMT) in benign prostatic hyperplasia (BPH).

Authors:  E Liatsikos; K Dadinis; G Barbalias
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

Review 4.  Changing therapeutic regimens in benign prostatic hyperplasia. Clinical and economic considerations.

Authors:  H J Stoevelaar; J McDonnell
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 5.  Minimally invasive devices for treating lower urinary tract symptoms in benign prostate hyperplasia: technology update.

Authors:  Fouad Aoun; Quentin Marcelis; Thierry Roumeguère
Journal:  Res Rep Urol       Date:  2015-08-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.